These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7558950)

  • 21. Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Bikas A; Van Nostrand D; Jensen K; Desale S; Mete M; Patel A; Wartofsky L; Vasko V; Burman KD
    Thyroid; 2016 Feb; 26(2):280-6. PubMed ID: 26649977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.
    Geinitz H; Zimmermann FB; Stoll P; Thamm R; Kaffenberger W; Ansorg K; Keller M; Busch R; van Beuningen D; Molls M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):691-8. PubMed ID: 11597810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
    Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
    J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Mell LK; Schomas DA; Salama JK; Devisetty K; Aydogan B; Miller RC; Jani AB; Kindler HL; Mundt AJ; Roeske JC; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1431-7. PubMed ID: 17996390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies.
    Kunos CA; Debernardo R; Radivoyevitch T; Fabien J; Dobbins DC; Zhang Y; Brindle J
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e35-41. PubMed ID: 22543208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
    Tanvetyanon T; Choudhury AM
    Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.
    Widlak P; Jelonek K; Wojakowska A; Pietrowska M; Polanska J; Marczak Ł; Miszczyk L; Składowski K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1108-1115. PubMed ID: 26031365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy.
    Scalliet P; Pignon T; de Haas-Kock D; Lambin P
    Eur J Cancer; 2001 Oct; 37 Suppl 7():S245-9. PubMed ID: 11887996
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
    Rose BS; Liang Y; Lau SK; Jensen LG; Yashar CM; Hoh CK; Mell LK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1185-91. PubMed ID: 22270171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
    Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R
    Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
    Seibold P; Webb A; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Calvo-Crespo P; Carballo A; Choudhury A; Cicchetti A; Claßen J; Delmastro E; Dunning AM; Elliott RM; Fachal L; Farcy-Jacquet MP; Gabriele P; Garibaldi E; Gómez-Caamaño A; Gutiérrez-Enríquez S; Higginson DS; Johnson K; Lobato-Busto R; Mollà M; Müller A; Payne D; Peleteiro P; Post G; Rancati T; Rattay T; Reyes V; Rosenstein BS; De Ruysscher D; De Santis MC; Schäfer J; Schnabel T; Sperk E; Symonds RP; Stobart H; Taboada-Valladares B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Ward T; Weißenberger C; West CML; Chang-Claude J;
    Radiother Oncol; 2019 Sep; 138():59-67. PubMed ID: 31146072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hyperbaric oxygen therapy on complete blood count.
    Gunes AE; Aktas S
    Undersea Hyperb Med; 2017; 44(4):357-364. PubMed ID: 28783892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of Heterogeneous Radiation Exposure Using Hematology and Blood Chemistry.
    Gaber MW; Rodgers SP; Tang TT; Sabek OM; Zawaski JA
    Radiat Res; 2020 Jan; 193(1):24-33. PubMed ID: 31671011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of recombinant human granulocyte colony-stimulating factor on efficacy of radiation therapy in tumor-bearing rats.
    Kabaya K; Watanabe M; Kusaka M; Akahori H; Seki M; Fushiki M
    Radiat Res; 1994 Jul; 139(1):92-6. PubMed ID: 7517051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
    de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
    J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.